woman in white scrub suit holding gray laptop computer

Transforming bladder cancer diagnosis

A simple urine test, more accurate and non-invasive.

Non-invasive
“Just a urine sample — no pain.”

High accuracy
“Over 90% sensitivity and specificity.”

Sustainable cost
“33% more affordable than the competition.”

Non Invasive Diagnostic

Explor Opportunities

Ask for Information

Danae UroGeomics

Danae Urogenomics is a leading company in bladder cancer diagnostics. Our state-of-the-art diagnostic systems allow us to offer high-quality services for the detection and monitoring of this disease. We collaborate with scientific institutions and hospitals to continuously improve our diagnostic and prognostic methods. Our scientific partnerships and institutional collaborations ensure the accuracy and effectiveness of our diagnostics.

At Danae Urogenomics, we offer innovative and non-invasive urine-based diagnostic solutions for bladder cancer, enhancing diagnostic accuracy and supporting personalized therapeutic decisions. Our mission is to contribute to a more efficient, less invasive, and patient-centered medicine through the implementation of cutting-edge technology.

Mission

Vision

To become global leaders in the detection and management of bladder cancer, setting new standards in non-invasive diagnostics and personalized care. We aspire to transform the clinical approach to cancer worldwide through precision technology-based solutions that improve therapeutic outcomes and patients' quality of life.

Mission & Vision

BlaDimiR

In vitro diagnosis
Detection of bladder cancer in urine
Measurement of specific microRNAs
Quantitative PCR (qPCR)
Accurate and non-invasive
No cystoscopy needed

Anticipates the effectiveness of combined BCG and anti-PD-L1 therapies
Joint analysis of miRNAs and cytokines in urine
Enables precise patient stratification
Valid for complex clinical contexts

BlaDimiRplus

Products

BlaDimiRIO

Predicts the likelihood of response to BCG immunotherapy
Detects a specific miRNA signature in urine
Enables personalized therapeutic decisions from early stages

Contact Us Now

Complete the form below to get in touch

Data protection: Danae Urogenomics S.L. will process your personal data to respond to your enquiry and manage related communications, based on legitimate interests or, where applicable, steps taken at your request before entering into a contract with you. Data relating to enquiries that do not lead to a professional, commercial or contractual relationship will be retained for no longer than 12 months from the last relevant interaction. Other retention circumstances are explained in our Privacy Policy. You can exercise your rights by emailing info@durogenomics.com.

For further information, please see our Privacy Policy.

Notice: do not include personal medical information, patient data or clinical results.